Insights

Market Leadership Indian Immunologicals Limited is the dominant player in veterinary and human vaccines in India, with extensive product offerings and a strong presence in public health programs. This positions the company as a reliable partner for government and large-scale health initiatives, presenting sales opportunities for supply of vaccines and ancillary products.

Innovative Product Launches Recent launches such as India's first indigenously developed DIVA marker vaccine, Hepatitis A vaccine, and ongoing development of monoclonal antibodies and Zika vaccines highlight IIL's focus on innovation. These advancements open doors for collaboration and sales of specialized vaccine technology and related biopharmaceutical products.

Global Export Potential Export activities to over 50 countries show IIL’s capabilities in meeting international vaccine standards. This expands potential sales opportunities for vaccine raw materials, international distribution partnerships, and technology licensing in emerging markets.

Technological Edge IIL’s use of advanced bio-manufacturing and logistical infrastructure ensures high-quality, cold chain-capable distribution. These capabilities make IIL a strategic supplier to large healthcare providers and supply chain partners seeking reliable vaccine delivery solutions.

Financial and Growth Prospects With revenues estimated between $100 million and $250 million and a steady pipeline of innovative products, IIL offers a promising opportunity for investors and bulk buyers interested in the biotechnology and vaccine segments, especially in emerging markets and government tenders.

Similar companies to Indian Immunologicals Limited

Indian Immunologicals Limited Tech Stack

Indian Immunologicals Limited uses 8 technology products and services including JSON-LD, MooTools, Element UI, and more. Explore Indian Immunologicals Limited's tech stack below.

  • JSON-LD
    Javascript Frameworks
  • MooTools
    Javascript Frameworks
  • Element UI
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • reCAPTCHA
    Security
  • HSTS
    Security
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

Media & News

Indian Immunologicals Limited's Email Address Formats

Indian Immunologicals Limited uses at least 1 format(s):
Indian Immunologicals Limited Email FormatsExamplePercentage
Last@indimmune.comDoe@indimmune.com
66%
First@indimmune.comJohn@indimmune.com
15%
FirstLast@indimmune.comJohnDoe@indimmune.com
11%
L.First@indimmune.comD.John@indimmune.com
8%

Frequently Asked Questions

Where is Indian Immunologicals Limited's headquarters located?

Minus sign iconPlus sign icon
Indian Immunologicals Limited's main headquarters is located at Road #44 Jubilee Hills Hyderābād, Telangana India. The company has employees across 4 continents, including AsiaNorth AmericaEurope.

What is Indian Immunologicals Limited's phone number?

Minus sign iconPlus sign icon
You can contact Indian Immunologicals Limited's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Indian Immunologicals Limited's official website and social media links?

Minus sign iconPlus sign icon
Indian Immunologicals Limited's official website is indimmune.com and has social profiles on LinkedIn.

What is Indian Immunologicals Limited's SIC code NAICS code?

Minus sign iconPlus sign icon
Indian Immunologicals Limited's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Indian Immunologicals Limited have currently?

Minus sign iconPlus sign icon
As of April 2026, Indian Immunologicals Limited has approximately 1.9K employees across 4 continents, including AsiaNorth AmericaEurope. Key team members include Chief Marketing Officer: D. S. J.Chief Marketing Officer: D. J.Chief Manager, Medical Services: D. P. S.. Explore Indian Immunologicals Limited's employee directory with LeadIQ.

What industry does Indian Immunologicals Limited belong to?

Minus sign iconPlus sign icon
Indian Immunologicals Limited operates in the Biotechnology Research industry.

What technology does Indian Immunologicals Limited use?

Minus sign iconPlus sign icon
Indian Immunologicals Limited's tech stack includes JSON-LDMooToolsElement UIjQueryreCAPTCHAHSTSApacheApache HTTP Server.

What is Indian Immunologicals Limited's email format?

Minus sign iconPlus sign icon
Indian Immunologicals Limited's email format typically follows the pattern of Last@indimmune.com. Find more Indian Immunologicals Limited email formats with LeadIQ.

When was Indian Immunologicals Limited founded?

Minus sign iconPlus sign icon
Indian Immunologicals Limited was founded in 1982.

Indian Immunologicals Limited

Biotechnology ResearchTelangana, India1001-5000 Employees

Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products.

IIL operates one of the largest plants in the world for veterinary vaccines. IIL has adequate infrastructure and cold chain distribution capability to reach out to various parts of India and world market. This flexibility in logistics has ensured many products of IIL occupy top slots in the market.

IIL is a major player in the human vaccine market in India, focusing on the pediatric and rabies vaccine segments. IIL is also a major supplier of pediatric vaccines to India’s large Universal Immunization Programme.

Brief History of IIL: 

Indian Immunologicals was established by the National Dairy Development Board (NDDB) in 1982, as its unit, with the objective of making vaccines available to farmers at an affordable price. The unit was incorporated as Indian Immunologicals Limited in the year 1999.

IIL started manufacturing human vaccines in 1998 on a specific request by the Government of India. IIL is the second company in the world and first in India to launch purified vero cell rabies vaccine (PVRV) and markets it under the brand – Abhayrab. This led to the discontinuation of use of older and unsafe sheep brain derived vaccine (also termed Nerve Tissue Vaccine – NTV) in the country.
IIL has also been exporting Animal Health vaccines,formulations & Human Health vaccines, to more than 50 countries. 
IIL not only provides products and services to enhance the quality of livestock in the country, but also utilizes its technological capabilities for the benefit of the people.

Section iconCompany Overview

Headquarters
Road #44 Jubilee Hills Hyderābād, Telangana India
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1982
Employees
1001-5000

Section iconFunding & Financials

  • $100M$250M

    Indian Immunologicals Limited's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Indian Immunologicals Limited's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.